NEW YORK (GenomeWeb) – Organism design company Ginkgo Bioworks announced today that it has raised $100 million in a Series C funding round.

The firm said it plans to use the funds to grow into new markets such as commodity chemicals, industrial enzymes, and human health markets. It also plans to build a next-generation automated foundry called Bioworks2 where Ginkgo's organism engineers can develop new designs at a larger scale.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new study in JAMA finds that genetic tests might not be able to determine what diet is right for someone seeking to lose weight.

A genome-wide association study that linked common genetic variants to salivary gland carcinoma risk has been retracted, according to Retraction Watch.

Vampire bats' ability to live off blood is etched in their genomes and gut microbiomes, the Scientist reports.

In Genome Biology this week: peopling of the Sahara, epigenetic reprogramming analysis of liverwort, and more.